Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
State Street SPDR S&P Biotech ETF
(NY:
XBI
)
154.03
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EDT, Sep 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,072
Open
154.03
Bid (Size)
154.61 (200)
Ask (Size)
154.90 (800)
Prev. Close
154.03
Today's Range
154.03 - 154.03
52wk Range
92.64 - 169.89
Shares Outstanding
541,500
Dividend Yield
0.18%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Breakfast News: A Conversation With Ionis CEO
↗
August 22, 2026
Ionis Pharmaceuticals CEO on a major profitability milestone, breakthrough medicines and more.
Via
The Motley Fool
Topics
ETFs
World Trade
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?
↗
August 20, 2026
XBI is up nearly 80% over the past year, but has experienced a much larger maximum drawdown over the past five years. IHE has delivered steadier returns and offers a higher dividend yield.
Via
The Motley Fool
Topics
ETFs
Performance
YTD
+26.8%
+26.8%
1 Month
-3.4%
-3.4%
3 Month
+13.8%
+13.8%
6 Month
+24.0%
+24.0%
1 Year
+64.9%
+64.9%
More News
Read More
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?
↗
August 19, 2026
Via
The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
↗
August 18, 2026
Via
The Motley Fool
Topics
ETFs
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?
↗
August 08, 2026
Via
The Motley Fool
Topics
ETFs
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?
↗
August 03, 2026
Via
The Motley Fool
Topics
ETFs
Here's How Much $100 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth Today
↗
July 13, 2026
Via
Benzinga
Topics
ETFs
Stocks
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?
↗
July 09, 2026
Via
The Motley Fool
Topics
ETFs
Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?
↗
July 05, 2026
Via
The Motley Fool
Topics
ETFs
The Best Biotech Stocks to Buy in 2026
↗
June 17, 2026
Via
The Motley Fool
Topics
ETFs
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
↗
June 17, 2026
Via
The Motley Fool
Topics
ETFs
3 Longevity ETFs to Buy and Hold (and Hold)
↗
June 08, 2026
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
↗
June 05, 2026
Via
The Motley Fool
Topics
ETFs
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost
↗
May 28, 2026
Via
The Motley Fool
Topics
ETFs
2 Ways to Play the Big Pharma Patent Cliff
↗
May 15, 2026
Via
MarketBeat
Topics
ETFs
Intellectual Property
Small Caps Under Siege: Russell 2000 Enters Correction as Yields Surge
March 23, 2026
Via
MarketMinute
Topics
Bonds
ETFs
Economy
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
↗
March 21, 2026
Via
The Motley Fool
Topics
Derivatives
ETFs
Regulatory Compliance
IBRX Stock Rises Overnight: Retail Bets Anktiva’s NCCN 'Recommended' Tag Will Drive Prescriptions And Insurance Wins
↗
March 17, 2026
Via
Stocktwits
Topics
ETFs
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
March 12, 2026
Via
Finterra
Topics
ETFs
Intellectual Property
Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest?
↗
March 11, 2026
Via
Stocktwits
Topics
ETFs
QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit
↗
March 10, 2026
Via
Stocktwits
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure
↗
March 10, 2026
Via
Stocktwits
Topics
Initial Public Offering
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150
↗
March 09, 2026
Via
Stocktwits
IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data
↗
March 09, 2026
Via
Stocktwits
ALT Stock Drops On Wider-Than-Expected Q4 Loss: Retail Voices Hopes For Deal To Alleviate Cash Concerns
↗
March 05, 2026
Via
Stocktwits
Frequently Asked Questions
Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 154.03
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 09/15/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 83.41M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 83M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
